Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today ...

An increased risk of both invasive and superficial fungal infections was observed among patients who received TNF-α inhibitors for various conditions.

Caspofungin was approved for use in Costa Rica in October 2001 (Cancidas; Merck Sharp and Dohme) for patients older than 16 years, with invasive Candida spp. or Aspergillus spp. that fail to ...

Desai, L. Kovanda - Poster P2946: Deciphering Connections Between Isavuconazole Drug Exposures and Responses Among Different Infections: Invasive Candidiasis – L. Kovanda, A. Desai - Poster ...

Research on the gut microbiome has focused mainly on bacteria, but bacteriophages and fungi play critical roles as well, with significant influences on health and disease.

While Candida in healthy infants typically doesn’t pose serious problems, preterm babies are more likely to have invasive fungal disease caused by Candida. This is due to their weakened immune systems ...